New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
Welcome to the March 2016 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the March issue!
PharmSource Lead Sheet
Summary of Global Clinical Pipeline Activity
|Lead Type||February 2016||CY 2016|
|Total Drug Leads||315||722|
|Total Device &
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Senhwa Biosciences plans to initiate a Phase I/II clinical trial in H2 of 2016 with CX-5461 for the treatment of triple-negative breast cancer:
- Therapeutic Area: Oncology – Other
- Dosage Form: Oral
- API: Chemical – Normal potency
Get deeper information about the likely upcoming needs of Senhwa Biosciences, its pipeline, contacts and more in the PharmSource Lead Sheet. If you’re not yet a subscriber, click here to learn more.
Follow the Money: Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc. is a U.S. public biopharmaceutical company that focuses on the discovery and early development of therapeutic proteins and diagnostic tests. Since October 1, 2015, Amarantus has raised a total of $11 million.
What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support the clinical trial of its… read on
Capturing CRO Opportunities in the Medical Device and Diagnostic Market
by Katie Ludwick, Marketing Manager
Contract research organizations (CROs) seeking to capture business in the medical device and diagnostic segment face a unique range of challenges, most prominently the lack of information shared by medical device companies during the development process. There are ways to overcome the obstacles and win contract research business in the growing medical device and diagnostic segment.
CROs that aren’t pursuing business in the medical device and diagnostic field because they’re operating under the mistaken impression that the opportunities aren’t there are missing out on… read on
CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2016 Edition
A shrinking number of CMOs are getting the lion’s share of the contract manufactured new products. Jim Miller and the PharmSource intelligence team identified at least three harbingers of a likely sustained increase in NME approvals in coming years:
- Total approvals using a CMO grew, but the share of NDA that are outsourced was flat in 2015>
- The number of NDA approvals will continue to grow, which is good news for CMOs
- But outsourcing by global bio/pharma companies may be on the decline
PharmSource’s just-released Trend Report, CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2016 Edition, concludes that these factors will provide… read on
Bio/Pharmaceutical Outsourcing Report – Special DCAT Edition
Check out the special DCAT Edition of PharmSource’s proprietary industry briefing.
This monthly report reports on and analyzes major developments throughout the CMO industry. It provides expert insight into the significance of industry trends and what they mean for your business.
Deepen your understanding of what’s happening in commercial and clinical dose manufacturing and packaging, API small and large molecule, captive capacity, regulatory developments and more.
Get your copy from the PharmSource team at DCAT. Or click here to download your complimentary copy.
DCAT Week 2016
Pharmaceutical Outsourcing CMO Outlook
PharmSource president Jim Miller will give an overview of the contract dose market for solid dosage and sterile drug products, including key trends, capacity utilization and strategies for supplier differentiation at the Pharmaceutical Outsourcing program today, March 15 in the Waldorf Astoria’s Empire Room.
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Nathaniel Celentano at firstname.lastname@example.org / 1-703-383-4903, ext. 112 (ET USA).